Systemic Lupus Erythematosus (SLE)Symptoms, Doctors, Treatments, Advances & More
Learn About Systemic Lupus Erythematosus (SLE)
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Northwell Health Physician Partners Rheumatology At Great Neck
Richard Furie is a Rheumatologist practicing medicine in Great Neck, New York. Dr. Furie is rated as an Elite provider by MediFind in the treatment of Systemic Lupus Erythematosus (SLE). He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Lupus Nephritis, Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), and Discoid Lupus Erythematosus (DLE). Dr. Furie is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine/Rheumatology.
Montefiore At AECOM
Chaim Putterman, MD - Summary of Research Program and Goals. Dr. Putterman is rated as an Elite provider by MediFind in the treatment of Systemic Lupus Erythematosus (SLE). He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Lupus Nephritis, Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), and Vasculitis.
BIDMC - Division Of Rheumatology
George Tsokos is an Internal Medicine provider practicing medicine in Boston, Massachusetts. Dr. Tsokos is rated as an Elite provider by MediFind in the treatment of Systemic Lupus Erythematosus (SLE). He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Systemic Lupus Erythematosus (SLE), Lupus Nephritis, Cutaneous Lupus Erythematosus (CLE), and Arthritis. Dr. Tsokos is board certified in American Board Of Internal Medicine.
Summary: This is the first-in-human trial of MTS109 (mRNA-LNP). The goal of this clinical trial is to evaluate the safety, tolerability of intravenous injection of MTS109 in moderate to severe autoimmune diseases.
Background: Systemic lupus erythematosus (SLE) is a disease that affects females nine times more often than males. People with SLE are often treated with cyclophosphamide (CYC). But CYC can damage a woman s ovaries; it may cause infertility. A drug called GnRHa is sometimes given to protect the ovaries during CYC therapy. But no one really knows how effective GnRHa treatment is. This natural history survey wi...